Geode Capital Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.17M | Sell |
|
|||||
|
2025
Q1 | $5.23M | Buy |
|
|||||
|
2024
Q4 | $8.5M | Sell |
|
|||||
|
2024
Q3 | $10.5M | Sell |
|
|||||
|
2024
Q2 | $9.23M | Buy |
|
|||||
|
2024
Q1 | $14.1M | Buy |
|
|||||
|
2023
Q4 | $5.36M | Buy |
|
|||||
|
2023
Q3 | $3.72M | Buy |
|
|||||
|
2023
Q2 | $3.9M | Buy |
|
|||||
|
2023
Q1 | $3.11M | Buy |
|
|||||
|
2022
Q4 | $1.84M | Buy |
|
|||||
|
2022
Q3 | $1.01M | Buy |
|
|||||
|
2022
Q2 | $252K | Buy |
|
|||||
|
2022
Q1 | $524K | Buy |
|
|||||
|
2021
Q4 | $350K | Buy |
|
|||||
|
2021
Q3 | $535K | Buy |
|
|||||
|
2021
Q2 | $398K | Sell |
|
|||||
|
2021
Q1 | $884K | Buy |
|
|||||
|
2020
Q4 | $528K | Buy |
|
|||||
|
2020
Q3 | $1.43M | Buy |
|
|||||
|
2020
Q2 | $1.48M | Buy |
|
|||||
|
2020
Q1 | $439K | Buy |
|
|||||
|
2019
Q4 | $476K | Buy |
|
|||||
|
2019
Q3 | $431K | Hold |
|
|||||
|
2019
Q2 | $644K | Buy |
|
|||||
|
2019
Q1 | $620K | Buy |
|
|||||
|
2018
Q4 | $126K | Hold |
|
|||||
|
2018
Q3 | $232K | Hold |
|
|||||
|
2018
Q2 | $278K | Buy |
|
|||||
|
2018
Q1 | $138K | Hold |
|
|||||
|
2017
Q4 | $114K | Buy |
|
|||||
|
2017
Q3 | $66K | Hold |
|
|||||
|
2017
Q2 | $44K | Sell |
|
|||||
|
2017
Q1 | $53K | Buy |
|
|||||
|
2016
Q4 | $119K | Buy |
|
|||||
|
2016
Q3 | $203K | Buy |
|
|||||
|
2016
Q2 | $121K | Sell |
|
|||||
|
2016
Q1 | $187 | Sell |
|
|||||
|
2015
Q4 | $295K | Buy |
|
|||||
|
2015
Q3 | $263K | Buy |
|